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Genetic testing for spinal muscular 
atrophy
To the Editor: We read with interest the description relating 
to spinal muscular atrophy (SMA) in the black South African 
population.1 The authors have described an interesting local 
group. We are, however, concerned that this may not be 
representative of the whole of South Africa. 
We would be particularly interested to hear more about the 
clinical phenotype and epidemiology of this cohort of patients. 
The authors have, for example, included phenotypic patients 
with facial weakness in their grouping. This is of significance 
because the international guidelines (ENMC, 1998) regard 
these as exclusion criteria for SMA.2  In our cohort of patients, 
facial weakness in the SMA molecularly genetically confirmed 
group is not a feature. Our 4 patients who presented with facial 
weakness, and were found to be negative for the common SMN 
(survival motor neuron) gene mutation, were subsequently 
confirmed to have other pathologies (congenital myopathy or 
congenital dystrophy). 
We are concerned that the authors’ findings are not 
representative of the whole of South Africa and that incorrect 
genetic advice could therefore be given to families and patients 
of indigenous African descent. As described in our paper,3 
we found no deviation from the international detection rate 
for the common SMN gene deletion (95 - 100%), regardless of 
our patients’ ancestry. This paper was published in 2002. Our 
figures have not altered since then and have now increased to a 
total of 50 patients assessed clinically and genetically confirmed 
to have SMA, with 22 being of indigenous African origin. We 
have had no patients of indigenous African origin referred 
through the services who complied with the international 
guidelines for SMA and were negative for the common SMN 
gene deletion on genetic testing.  
This discrepancy in SMA findings between two geographi-
cally distinct institutions is of diagnostic import, and we look 
forward to the published evidence from the authors that their 
discordant black patients have some other defect, either 
ised to the SMN gene or impacting on SMN gene expression.
Jo M Wilmshurst
Felicity Leisang
Howard Hendersen  
Departments of Paediatric Neurology and
Chemical Pathology 
Red Cross War Memorial Children’s Hospital and 
University of Cape Town 
wilmshur@ich.uct.ac.za
1. Labrum R, Krause A, Rodda J. Genetic testing for spinal muscular atrophy (SMA) in South 
Africa. S Afr Med J 2006; 96: 200.
2. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised 
diagnostic criteria. 17-19 April 1998, Soestduinen, The Netherlands. Neuromuscl Disord 1999; 
9: 272-278.
3. Wilmshurst JM, Reynolds L, Toorn VR, Leisegang F, Henderson HE. Spinal muscular atrophy 
in black South Africans: Concordance with the universal SMN1 genotype. Clin Genet 2002; 62: 
165-168. 
New protocol for HIV screening for life 
assurance
To the Editor: The insurance industry has used the third-
generation ELISA protocol as a screening test for human 
immunodeficiency virus (HIV) infection over the last number 
of years. In order to utilise new technology and keep up with 
developments in the clinical field, the fourth-generation Combi 
protocol has been developed in consultation with experts and 
discussion with the National Pathology Group. The third-
generation protocol will be used concurrently with the fourth-
generation protocol for the next 2 years.
This protocol uses one of the LOASPA approved fourth-
generation combination HIV tests (Combi test). The Combi tests 
for both the HIV antibodies and the virus itself (P24, antigen 
component), shortening the window period from an average of 
16 days to an average of 7 days.
The Medical and Underwriting Standing Committee (MUSC) 
of the Life Offices’ Association of South Africa (LOA) has 
extensively investigated the results of the new test on local 
blood samples for the last 18 months. The aim was to ensure 
that there is not an increase in the false-positive test ratio, as 
this has serious implications. Two major studies have been 
done by Ampath and the University of Pretoria to compare the 
existing ELISA tests to the combination tests. The latter study is 
ongoing.
As with all underwriting tests, as well as the previous 
protocol, these tests must be regarded as screening tests and 
further testing is recommended in the event of a reactive test. 
Any further tests will be for the client’s own cost.
A non-reactive Combi test result is reported as such and no 
follow-up test is done. A new category of ‘low-reactive’ results 
has been defined. Any low-reactive or reactive result will be 
retested with a third-generation ELISA immuno-assay to retest 
the antibody component. If this does not confirm the result of 
the first test, it will be followed with a P24 antigen test to retest 
the antigen component. Any low-reactive third-generation test 
will also be followed with a P-2 antigen test. All second and 
third line follow-up tests will be from a different manufacturer 
than that of the Combi test (Fig. 1).  
Cut-off values for ‘reactive’ as well as ‘low reactive’ results 
for all approved third-generation ELISAs, as well as fourth-
generation Combi tests, will be defined from time to time by 
mutual agreement between the National Pathology Group and 
the Medical and Underwriting Standing Committee of the LOA.
The LOA is confident that the use of ‘low-reactive’ values 
with sequential follow-up tests of both the antigen and 
antibody components will reduce the possible number of false- 
reactive results to a minimum.
Further information is available on http://www.loa.co.za 
Chapter 6 HIV Testing Protocol.
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Abortion – an elusive moral cut-off 
point?  
To the Editor: The argument about some theoretical ‘cut-off’ 
point has an unrecognised objective: to deflect, allay or absolve 
Guilt in the aborting mother or the operator of the abortion. 
The Law also colludes with the immature behaviour of the 
population at large and does not encourage the development 
of adult responsibility in respect of contraception and family 
planning.
These arguments are based on ‘moral’ grounds, ignoring 
the higher issue of the spiritual self. To discount the Spirit is 
to discount humanity: you have a body, you have a mind … 
yet you are a spirit. Morality has to do with prevailing societal 
values of right and wrong, and these are as changeable as the 
weather.  The utilitarians’ view1 is flawed and makes apparent 
their ignorance of the realities of fetal life. Let us accept the 
premise that personhood entails an entity’s ability to suffer and 
an interest in the continuance of its existence. However, I reject 
outright that the latter interest develops ‘some time after birth’. 
Contrary to conventional wisdom the fetus does think, 
does have emotions and certainly displays survival behaviour. 
The truth is that the fetus is intensely concerned with its 
survivability – not only from a physical perspective but still 
more powerfully at an emotional and spiritual level.2 I have 
facilitated more than 1 000 such regressions, and a great many 
of the perceptions thus recalled were verified by the mothers 
of my patients. These events often begin with the mother’s 
awareness of the pregnancy – usually confirmed around 6 - 8 
weeks – and become magnified through the second and third 
trimesters. The weight of this evidence is based on many tens of 
thousands of such regressions, in South Africa and the USA. I 
no longer regard the fertilised ovum as a ‘potential’ person – it 
is a distinct entity imbued with a spiritual nature.
Separation-survivability theory operates from the perspective 
of physical survival but, with respect, ignores the great suffering 
experienced emotionally and spiritually by the fetus, and 
occasionally physically, from as early as the first trimester. 
It is here that the awareness of the threat to its survivability 
often begins. Without Love, a de facto condition in abortion, 
survivability is bleak indeed.
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To the Editor: The article by De Roubaix and Van Niekerk1 is 
interesting and thought provoking.
As they try to define the moral cut-off  point, they discuss 
different views on the time-old question – when does life begin? 
In my humble opinion, they left out one important theory: the 
pragmatic view.
Three clerics were talking about the beginning of life. 
Said the first: When the baby is born, with the first breath the 
soul enters the body and the life begins.
The second cleric disagreed: After the sperm hits the ovum, 
with the first division the life already begins.
So they asked the third one for his view. And the Rabbi 
promptly replied: When the kids are out of the house and the 
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AIDS prevention: Rapes, needlesticks 
and stabs
To the Editor: I recently attended the HIV course held in 
Durban by the Foundation for Professional Development. 
The course was most informative and brought to light some 
interesting statistics about HIV transmission rates in various 
scenarios. A comparison that I found most fascinating was that 
an individual had a 0.1 % risk of contracting the virus during 
a single episode of sexual intercourse, whereas a percutaneous 
exposure (such as a needlestick injury) posed a 3 times greater 
risk. This then got me thinking about the government’s current 
First-line test Combi: Reactive
Second-line test
Third-generation ELISA
Reactive Non-reactive or low-reactive
Third-line test No third-line test P-24 AG
Fig. 1. New fourth-generation HIV test protocol.
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